Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Nov 15;5(11):e385. doi: 10.1038/mtna.2016.94

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/

PMC Copyright notice

LINC00511 is upregulated in primary human NSCLC and NSCLC cell lines, and benefits for prognosis. (a,b) LINC00511 is significantly decreased in primary human NSCLC tissues in comparison to adjacent-normal NSCLC tissues. n = 124 for each group. (c) The expression level of LINC00511 in ten NSCLC cell lines and normal 16HBE cells. Assays were performed in triplicate. (d) Kaplan-Meier survival analysis revealed that high-expressed LINC00511 is associated with poor prognosis in patients with non–small-cell lung cancer. *P < 0.05, Means ± SD was shown. Statistical analysis was conducted using student t-test and Log Rank test. NSCLC, non–small-cell lung cancer.